Xiaoding Xu
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 25
- Nanoparticle-Based Drug Delivery 16
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 8
- Co-authors
- Phei Er Saw (38 shared papers)Jacob A. Moulijn (1 shared paper)Omid Cameron Farokhzad (13 shared papers)Jinjun Shi (12 shared papers)Wei Tao (11 shared papers)Xian‐Zheng Zhang (16 shared papers)Xiaoyuan Ji (5 shared papers)Ren‐Xi Zhuo (10 shared papers)
- Journals
- Advanced Science (6 papers)Angewandte Chemie International Edition (5 papers)Nano Letters (5 papers)ACS Nano (4 papers)Theranostics (4 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaoding Xu
115 papers receiving 6.8k citations
Xiaoding Xu's Hit Papers
Peers
Comparison fields: 5 of 138
- Biomaterials 1.7k
- Process Chemistry and Technology 217
- Catalysis 526
- Cancer Research 977
- Biomedical Engineering 2.4k
Countries citing papers authored by Xiaoding Xu
This map shows the geographic impact of Xiaoding Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoding Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoding Xu more than expected).
Fields of papers citing papers by Xiaoding Xu
This network shows the impact of papers produced by Xiaoding Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoding Xu. The network helps show where Xiaoding Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoding Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy Hit paper breakdown → | 2017 | 606 |
| 2 | ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy Hit paper breakdown → | 2017 | 460 |
| 3 | 1996 | 423 | |
| 4 | Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output Hit paper breakdown → | 2020 | 379 |
| 5 | 1987 | 255 | |
| 6 | 2016 | 248 | |
| 7 | 2015 | 224 | |
| 8 | 2018 | 204 | |
| 9 | 2017 | 189 | |
| 10 | 2020 | 154 | |
| 11 | 2008 | 148 | |
| 12 | 2019 | 141 | |
| 13 | 2020 | 135 | |
| 14 | 2019 | 123 | |
| 15 | 2020 | 121 | |
| 16 | 2017 | 119 | |
| 17 | 2020 | 117 | |
| 18 | 2018 | 104 | |
| 19 | 2018 | 97 | |
| 20 | 2008 | 96 |
About Xiaoding Xu
Xiaoding Xu is a scholar working on Biomaterials, Cancer Research, Molecular Biology, Biomedical Engineering and Molecular Medicine, having authored 117 papers that have together received 7.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (35 papers), Nanoplatforms for cancer theranostics (23 papers), Advanced biosensing and bioanalysis techniques (20 papers), Nanoparticle-Based Drug Delivery (16 papers), Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers), MicroRNA in disease regulation (8 papers) and Immune cells in cancer (8 papers). The work is most often cited by research in Biomaterials (1.7k citations), Process Chemistry and Technology (217 citations), Catalysis (526 citations), Cancer Research (977 citations) and Biomedical Engineering (2.4k citations). Xiaoding Xu has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Phei Er Saw, Jacob A. Moulijn, Omid Cameron Farokhzad, Jinjun Shi, Wei Tao, Xian‐Zheng Zhang, Xiaoyuan Ji, Ren‐Xi Zhuo, Joseph J. F. Scholten and Si‐Xue Cheng. Their work appears in journals such as Advanced Science, Angewandte Chemie International Edition, Nano Letters, ACS Nano and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.